Trends in heart failure mortality in Poland between 1980 and 2010;Trendy umieralnosci z powodu niewydolnosci serca w populacji polskiej w latach 1980-2010

Polskie Archiwum Medycyny Wewnetrznej

Volumn 123, Issue 12, 2013, Pages 664-671

  Rywik, Tomasz M ^a   Koziarek, Jacek ^a   Piotrowski, Walerian ^a   Leszek, Przemyslaw ^a   Rozentryt, Piotr ^b   Zielinski, Tomasz ^a   Korewicki, Jerzy ^a   Broda, Grazyna ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Heart failure; Mortality; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIDDLE AGED; POLAND; AGE DISTRIBUTION; EPIDEMIOLOGY; MORTALITY; SEX RATIO; SURVIVAL RATE; VERY ELDERLY;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; POLAND; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 84893705632     PISSN: 00323772     EISSN: 18979483     Source Type: Journal    
DOI: 10.20452/pamw.2007     Document Type: Article

References (35)

1. Laribi S, Aouba A, Nikolaou M, et al. Trends in death attributed to heart failure over the past two decades in Europe. Eur J Heart Fail. 2012; 14: 234-239.
2. Helis E, Augustincic L, Steiner S, et al. Time trends in cardiovascular and all-cause mortality in the "old" and "new" European Union countries. Eur J Cardiovasc Prev Rehabil. 2011; 18: 347-359.
3. Stanczak J. [Basic data regarding demographic development in Poland until year 2012]. Central Statistical Office. 2013. Polish.
4. Bandosz P, O'Flaherty M, Drygas W, et al. Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study. BMJ. 2012; 344: d8136.
5. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007; 93: 1137-1146.
6. Lien CT, Gillespie ND, Struthers AD, et al. Heart failure in frail elderly patients: diagnostic difficulties, co-morbidities, polypharmacy and treatment dilemmas. Eur J Heart Fail. 2002; 4: 91-98.
7. Rywik SL, Broda G, Jasinski B. Heart failure mortality and hospital morbidity in Polish population. Kardiol Pol. 1999; 50: 20-29.
8. Fonarow GC, Albert NM, Curtis AB, et al. Incremental Reduction in Risk of Death Associated With Use of Guideline-Recommended Therapies in Patients With Heart Failure: A Nested Case-Control Analysis of IMPROVE HF. J Am Heart Assoc. 2012; 1: 16-26.
9. Korewicki J, Rywik S, Rywik T. Management of heart failure patients in Poland. Eur J Heart Fail. 2002; 4: 215-219.
10. Engelfriet PM, Hoogenveen RT, Boshuizen HC, et al. To die with or from heart failure: a difference that counts: is heart failure underrepresented in national mortality statistics? Eur J Heart Fail. 2011; 13: 377-383.
11. Schaufelberger M, Swedberg K, Koster M, et al. Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000. Eur Heart J. 2004; 25: 300-307.
12. Sinner MF, Reinhard W, Muller M, et al. Association of early repolarization pattern on ECG with risk of cardiac and all-cause mortality: a population-based prospective cohort study (MONICA/KORA). PLoS Med. 2010; 7: e1 000 314.
13. Wojtyniak B, Jankowski K, Zdrojewski T, et al. Regional differences in determining cardiovascular diseases as the cause of death in Poland: time for change. Kardiol Pol. 2012; 70: 695-701.
14. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002; 347: 1397-1402.
15. Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA. 2004; 292: 344-350.
16. Najafi F, Dobson AJ, Jamrozik K. Is mortality from heart failure increasing in Australia An analysis of official data on mortality for 1997-2003. Bull World Health Organ. 2006; 84: 722-728.
17. Shafazand M, Schaufelberger M, Lappas G, et al. Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987-2003 from the Swedish Hospital Discharge Registry. Eur Heart J. 2009; 30: 671-678.
18. Goldacre MJ, Mant D, Duncan M, et al. Mortality from heart failure in an English population, 1979-2003: study of death certification. J Epidemiol Community Health. 2005; 59: 782-784.
19. Rutkowska L. Life expectancy tables of Poland 2011. Statistical Information and Elaborations. 2012; 1-80.
20. Rywik TM, Kolodziej P, Targonski R, et al. Characteristics of the heart failure population in Poland: ZOPAN, a multicentre national programme. Kardiol Pol. 2011; 69: 24-31.
21. Jhund PS, Macintyre K, Simpson CR, et al. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation. 2009; 119: 515-523.
22. Davidkovova H, Kysely J, Kriz B, et al. Trends in cardiovascular mortality and hospitalisations, and potential contribution of inhospital case-fatality rates to changes in national mortality in the Czech Republic 1994-2009. Heart. 2013; 99: 409-416.
23. Rodriguez-Artalejo F, Guallar-Castillon P, Banegas Banegas JR, et al. Trends in hospitalization and mortality for heart failure in Spain, 1980-1993. Eur Heart J. 1997; 18: 1771-1779.
24. Goldberg RJ, Glatfelter K, Burbank-Schmidt E, et al. Trends in mortality attributed to heart failure in Worcester, Massachusetts, 1992 to 2001. Am J Cardiol. 2005; 95: 1324-1328.
25. Redfield MM, Jacobsen SJ, Burnett JC Jr, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003; 289: 194-202.
26. Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011; 8: 30-41.
27. Zarrinkoub R, Wettermark B, Wandell P, et al. The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden. Eur J Heart Fail. 2013; 15: 995-1002.
28. Cowie MR, Wood DA, Coats AJ, et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart. 2000; 83: 505-510.
29. Banasiak W. Diagnostic and therapeutic problems in heart failure. Pol Arch Med Wewn. 2008; 118: 485-488.
30. Loh JC, Creaser J, Rourke DA, et al. Temporal trends in treatment and outcomes for advanced heart failure with reduced ejection fraction from 1993-2010: findings from a university referral center. Circ Heart Fail. 2013; 6: 411-419.
31. Murdoch DR, Love MP, Robb SD, et al. Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979-1992. Eur Heart J. 1998; 19: 1829-1835.
32. Koelling TM, Chen RS, Lubwama RN, et al. The expanding national burden of heart failure in the United States: the influence of heart failure in women. Am Heart J. 2004; 147: 74-78.
33. Lenzen MJ, Boersma E, Reimer WJ, et al. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. Eur Heart J. 2005; 26: 2706-2713.
34. Najafi F, Jamrozik K, Dobson AJ. Understanding the 'epidemic of heart failure': a systematic review of trends in determinants of heart failure. Eur J Heart Fail. 2009; 11: 472-479.
35. Go AS, Mozaffarian D, Roger VL, et al. Executive Summary: Heart Disease and Stroke Statistics -2013 Update: A Report From the American Heart Association. Circulation. 2013; 127: 143-152.